82 related articles for article (PubMed ID: 1580798)
1. Effects of a thromboxane synthetase inhibitor (OKY-046) on vascular reactivity to angiotensin II after stricture of the abdominal aorta in pregnant rabbits.
Ushijima H; Ito M; Yoshimura T; Mabe K; Okamura H
Artery; 1992; 19(2):63-75. PubMed ID: 1580798
[TBL] [Abstract][Full Text] [Related]
2. [Effect of endothelium-derived nitric oxide and prostaglandins on the endothelium-dependent vascular refractoriness to angiotensin II in pregnant rabbits].
Nakamoto O; Hidaka A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1149-56. PubMed ID: 1453044
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
4. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
Hirano T; Nakafusa Y; Kawano R; Motoyama K; Arima T; Sugitani A; Tanaka M
Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
[TBL] [Abstract][Full Text] [Related]
5. Effect of a low calcium intake on the vascular sensitivity to angiotensin II in normotensive pregnant rats.
Aiko A; Ito M; Okamura H; Araki H; Nishi K
Artery; 1992; 19(4):199-210. PubMed ID: 1520073
[TBL] [Abstract][Full Text] [Related]
6. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of thromboxane A2 synthetase inhibitor (OKY-046) on 24-hr simple hypothermic preservation of the canine pancreas graft.
Nagami H; Tamura K; Kin S; Teramoto M; Ishida T
Int Surg; 1995; 80(3):274-7. PubMed ID: 8775620
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane synthetase inhibition and thromboxane receptor blockade preserve pulmonary and circulatory function in a porcine burn sepsis model.
Iglesias G; Zeigler ST; Lentz CW; Traber DL; Herndon DN
J Am Coll Surg; 1994 Aug; 179(2):187-92. PubMed ID: 8044389
[TBL] [Abstract][Full Text] [Related]
9. Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model.
Tokyay R; Loick HM; Traber DL; Heggers JP; Herndon DN
Surg Gynecol Obstet; 1992 Feb; 174(2):125-32. PubMed ID: 1734570
[TBL] [Abstract][Full Text] [Related]
10. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
11. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
12. Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats.
Furuhashi N; Tsujiei M; Kimura H; Nagae H; Yajima A
Gynecol Obstet Invest; 1993; 35(1):23-6. PubMed ID: 8449429
[TBL] [Abstract][Full Text] [Related]
13. The role of prostanoid in hepatic damage during hepatectomy.
Shirabe K; Takenaka K; Yamamoto K; Kitamura M; Itasaka H; Matsumata T; Shimada M; Sugimachi K
Hepatogastroenterology; 1996; 43(9):596-601. PubMed ID: 8799402
[TBL] [Abstract][Full Text] [Related]
14. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats.
Tanaka M; Natori M; Ishimoto H; Miyakoshi K; Miyazaki T; Kobayashi T; Yoshimura Y
Biol Neonate; 1997; 72(3):181-6. PubMed ID: 9303217
[TBL] [Abstract][Full Text] [Related]
15. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
Edmonds LC; Lefer AM
Life Sci; 1984 Oct; 35(17):1763-8. PubMed ID: 6434893
[TBL] [Abstract][Full Text] [Related]
16. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB
Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299
[TBL] [Abstract][Full Text] [Related]
17. A study on the effectiveness of a thromboxane synthetase inhibitor (OKY-046) in increasing the survival length of skin flaps.
Ono I; Ohura T; Murazumi M; Sakamura R; Chiba S
Plast Reconstr Surg; 1990 Dec; 86(6):1164-73. PubMed ID: 2147062
[TBL] [Abstract][Full Text] [Related]
18. Effects of a selective thromboxane synthetase inhibitor OKY-046 on experimental diabetic nephropathy.
Hora K; Oguchi H; Furukawa T; Hora K; Tokunaga S
Nephron; 1990; 56(3):297-305. PubMed ID: 2077412
[TBL] [Abstract][Full Text] [Related]
19. Effects of highly purified eicosapentaenoic acid on vascular reactivity to angiotensin II and norepinephrine in pregnant rabbits.
Yoshimura T; Ito M; Matsui K; Okamura H
Artery; 1997; 22(5):242-50. PubMed ID: 9209697
[TBL] [Abstract][Full Text] [Related]
20. Effect of thromboxane synthetase inhibitor on cerebral circulation and metabolism during experimental cerebral ischemia in spontaneously hypertensive rats.
Sadoshima S; Ooboshi H; Okada Y; Yao H; Ishitsuka T; Fujishima M
Eur J Pharmacol; 1989 Oct; 169(1):75-83. PubMed ID: 2513212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
